Purchase Order 75N95021P00013
Award Date
11/9/20
Potential Completion Date
5/8/21
Potential Value
$92K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
QPS LLC
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
B504 - Special Studies/Analysis- Chemical/Biological
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newark, DE, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Southern Research Institute for $27,500.00. The contract is for assay development to measure the SARS-CoV-2 antiviral effect of remdesivir and the development of an AlphaLISA assay to be conducted under biosafety level 3 (BSL-3) conditions. This non-competitive contract was awarded without full and open competition due to...
This is a $37,000 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Southern Research Institute. The contract is for COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 CPE assay. This non-competitive award was made under simplified acquisition procedures, with the vendor selected due to prior work on the compound testing. The period of performance runs through...
This firm-fixed-price purchase order contract, valued at $47,000.00, was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Southern Research Institute, a non-profit organization, for COVID-19 compound dose response testing. The contract has no set-aside designation and is part of NCATS' efforts to evaluate potential COVID-19 treatments. Southern Research Institute has a history of providing drug discovery, development, and testing services to...
This is a $37,000.00 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences, part of the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization, for compound testing and cytotoxicity screening related to SARS-CoV-2. The contract does not have a set-aside designation. Through past federal contracts and grants, Southern Research has provided a range of research and development services...
This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), to BIOIVT, LLC, a leading global provider of biological specimens and services. The $23,290 contract is for an in vitro transporter assessment of the COVID-19-related compound GS-441524, which is a potential oral treatment for COVID-19. The award supports NCATS' mission to advance the development of diagnostics and...
This federal contract award, valued at $91,000.00, was issued by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Novotech Drug Development Consulting LLC, doing business as CBR International, LLC, a small business. The contract provides regulatory support services for a pre-Investigational New Drug (IND) application meeting with the U.S. Food and Drug Administration (FDA)...
This is a $160,000 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Metabolon, Inc., a small disadvantaged business. The contract is for metabolomic profiling of 800 plasma biospecimens collected from COVID-19 patients and appropriate controls, in order to generate metabolic profiles to support research initiatives related to the coronavirus pandemic. The contract was awarded...
This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to the Southern Research Institute, a non-profit research organization. The $42,000 contract is for COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 CPE assay. This work supports NCATS' mission of advancing the translation of medical discoveries into clinical applications. The contract has no...
This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Southern Research Institute to conduct COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 cytopathic effect (CPE) assay across two rounds. The $74,000.00 contract has an ultimate completion date of August 28, 2020 and was not set aside for any specific business type. Southern Research Institute is a...
This $16,260.00 firm-fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The contract is for COVID-19/coronavirus-related services, including method development for liquid chromatography-mass spectrometry (LC-MS/MS) analysis of 1 compound, and uptake transporter screening/identification for 2 concentrations and 2 time points using a...